logo

MED

Medifast·NYSE
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
5.71 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is MED a Good Buy Right Now?
  • Based on a composite score of 5.71/10, we rate MED as a Netural. Our analysis breaks down into 9.91/10 for Fundamentals, 2.90/10 for Technicals, and 5.03/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MED undervalued or overvalued?
Technical Analysis of MED?
What is the analyst consensus for MED?